Tonix Pharmaceuticals : Announces Trial Design of New Phase 2 Clinical Study of TNX-1300 for Cocaine Intoxication - Form 8-K
Tonix Pharmaceuticals Announces Trial Design of New Phase 2 Clinical Study of TNX-1300 for Cocaine Intoxication New Trial Design is Single-Blind, Placebo-Controlled, Potential... | June 27, 2022
Source: marketscreener.com